Fluvoxamine as a Cause of Stimulation, Mania, and Aggression: A Critical Analysis of the FDA-Approved Label
The contents of the FDA-approved label for Luvox (fluvoxamine) are compared to the known risks of fluvoxamine-induced stimulation, mania, and aggression in children and adults. It is found that the label in many ways fails to communicate the severity and range of these drug-induced adverse mental and behavioral drug effects. Health professionals need to approach government-approved labels with skepticism and scientific sophistication, especially in regard to evaluating the risks of medications.
No References for this article.
No Supplementary Data.
No Article Media
Document Type: Journal Article
Affiliations: Ithaca, NY
Publication date: January 1, 2002
More about this publication?
- Please go to http://connect.springerpub.com/content/sgrehpp to access your online subscription to Ethical Human Services and Sciences.